跳至主要内容
临床试验/NCT05925699
NCT05925699尚未招募不适用

National Database of the Virtual Institute of Cerebrovascular Diseases

Fondazione Policlinico Universitario Agostino Gemelli IRCCS1 个研究点 分布在 1 个国家目标入组 285,600 人开始时间: 2023年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
285,600
试验地点
1
主要终点
Identification of subtypes of each cerebrovascular disease (ICD-9 430-438) associated with poor prognosis.

研究概览

简要总结

The primary aim of the study is to develop a national registry of cerebrovascular diseases in order to define the subtypes of these diseases associated with a worse prognosis. Secondly, the study aims to find clinical, radiological, and biological markers capable tof predicting the outcome of cerebrovascular diseases and the onset of complications related to therapeutic procedures, and to calculate predictive prognostic scores composed of multiple variables.

Each participating center will collect clinical, radiological, and biological data from the medical records of the study participants. Patients included in the study will not undergo any additional medical procedures to those of normal clinical practice.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

性别
All
接受健康志愿者

入选标准

  • Diagnosis of cerebrovascular pathology defined according to the NINDS special report of 1990 as "all disorders in which there is an area of the brain transiently or permanently affected by ischemia or bleeding and/or in which one or more blood vessels of the brain are mainly altered by a pathological process", falling within the following codes of the International Classification of Diseases, 9th revision (ICD-9): ICD-9 430-438;
  • Informed consent provided by the patient or his legal representative in the case of mental incapacity or by the parents/guardians in the case of minors.

排除标准

  • The patient, his legal representative in the case of mental incapacity or his parents/guardians in the case of minors clearly state their will to leave the study;
  • Onset of cerebrovascular disease before January 1, 2016.

结局指标

主要结局

Identification of subtypes of each cerebrovascular disease (ICD-9 430-438) associated with poor prognosis.

时间窗: July 1, 2023 - July 1, 2053

Identification and definition of the various subtypes of each cerebrovascular disease (International Classification of Diseases, 9th revision (ICD-9): ICD-9 430-438) associated with poor prognosis.

次要结局

  • Identification of radiological variables of each cerebrovascular disease able to predict the success of pharmacological or procedural therapies(July 1, 2023 - July 1, 2053)
  • Identification of neurophysiological variables of each cerebrovascular disease helping in differential diagnosis(July 1, 2023 - July 1, 2053)
  • Identification of clinical variables of each cerebrovascular disease capable of predicting the development of complications(July 1, 2023 - July 1, 2053)
  • Identification of radiological variables of each cerebrovascular disease helping in differential diagnosis(July 1, 2023 - July 1, 2053)
  • Identification of neurophysiological variables of each cerebrovascular disease capable of predicting the development of complications(July 1, 2023 - July 1, 2053)
  • Identification of radiological variables of each cerebrovascular disease capable of predicting the development of complications(July 1, 2023 - July 1, 2053)
  • Identification of biomarkers of each cerebrovascular disease helping in differential diagnosis(July 1, 2023 - July 1, 2053)
  • Identification of clinical variables of each cerebrovascular disease correlated with its prognosis(July 1, 2023 - July 1, 2053)
  • Identification of radiological variables of each cerebrovascular disease correlated with its prognosis(July 1, 2023 - July 1, 2053)
  • Identification of neurophysiological variables of each cerebrovascular disease correlated with its prognosis(July 1, 2023 - July 1, 2053)
  • Identification of prognostic scores for each cerebrovascular disease(July 1, 2023 - July 1, 2053)
  • Identification of biomarkers of each cerebrovascular disease capable of predicting the development of complications(July 1, 2023 - July 1, 2053)
  • Identification of biomarkers of each cerebrovascular disease able to predict the success of pharmacological or procedural therapies(July 1, 2023 - July 1, 2053)
  • Identification of biomarkers of each cerebrovascular disease correlated with its prognosis(July 1, 2023 - July 1, 2053)
  • Identification of clinical variables of each cerebrovascular disease helping in differential diagnosis(July 1, 2023 - July 1, 2053)
  • Identification of clinical variables of each cerebrovascular disease able to predict the success of pharmacological or procedural therapies(July 1, 2023 - July 1, 2053)
  • Identification of the clinical variables of each cerebrovascular disease useful for the personalization of the rehabilitation treatment and able to predict its functional outcome(July 1, 2023 - July 1, 2053)
  • Identification of the radiological variables of each cerebrovascular disease useful for the personalization of the rehabilitation treatment and able to predict its functional outcome(July 1, 2023 - July 1, 2053)
  • Identification of the neurophysiological variables of each cerebrovascular disease useful for the personalization of the rehabilitation treatment and able to predict its functional outcome(July 1, 2023 - July 1, 2053)
  • Identification of the biomarkers of each cerebrovascular disease useful for the personalization of the rehabilitation treatment and able to predict its functional outcome(July 1, 2023 - July 1, 2053)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Calabresi Paolo

Professor, Head of Neurology Department

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

研究点 (1)

Loading locations...

相似试验